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Purpose: To evaluate the effects of low energy availability (EA) on health and performance 
indices associated with the Male Athlete Triad and Relative Energy Deficiency in Sports (RED-
S) models. Methods: Over an 8 week period, a male combat sport athlete adhered to a phased 
body mass (BM) loss plan consisting of 7 weeks energy intake (EI) equating to resting metabolic 
rate (RMR) (1700 kcal·day
-1
) (Phase 1), 5 days of reduced EI (1200-300 kcal·day
-1
) prior to 
weigh-in (Phase 2) and one week of ad libitum EI post-competition (Phase 3). EA fluctuated day 
by day due to variations in exercise energy expenditure. Regular assessments of body 
composition, RMR, cardiac function, cardiorespiratory capacity, strength & power, 
psychological state and blood clinical chemistry for endocrine, bone turnover, hydration, 
electrolyte, renal, liver and lipid profiles were performed. Results: BM was reduced over the 8 
week period by 13.5% (72.5 to 62.7 kg). No consequences of Male Athlete Triad or RED-S were 
evident during phase 1, where mean daily EA equated to 20 kcal·kg·FFM·day
-1
 (range: 7 to 31 
kcal·kg·FFM·day
-1
) and BM and fat mass (FM) losses were 6.5 and 4.4 kg, respectively.  
However, consequences did present in phase 2 when mean daily EA was consistently <10 
kcal·kg·FFM·day
-1
, as evidenced by alterations to endocrine hormones (e.g. testosterone: <5 
nmol.L
-1
) and reduced RMR (-257 kcal·day
-1
). Conclusion: Data demonstrate that 7 weeks of 
daily fluctuations in EA equating to a mean value of 20 kcal·kg·FFM·day
-1 
permits reductions of 
BM and FM without perturbations to physiological systems associated with the Male Athlete 
Triad and RED-S. In contrast, a subsequent period of 5 consecutive days of EA <10 
kcal·kg·FFM·day
-1
 induced consequences of Male Athlete Triad and RED-S.  Key Words: 
MALE ATHLETE TRIAD, RELATIVE ENERGY DEFICIENCY IN SPORTS, WITHIN DAY 
ENERGY BALANCE, REBOUND HYPERPHAGIA 






Combat sport athletes compete within designated weight categories that are intended to promote 
fair competition by matching opponents of equal stature and body mass (BM) (1). In an attempt 
to qualify for lowest weight category possible (often referred to as “making weight”), these 
athletes typically engage in practices associated with acute and chronic BM loss, many of which 
are detrimental to health and performance (2). In the acute phase (i.e. within hours to days prior 
to official weigh in), combat sport athletes often employ combinations of active and passive 
dehydration techniques, where 5-10% reductions in BM have been observed (3). These practices 
may cause acute kidney injury and in extreme situations, can even lead to death (4, 5). As such, 
there is a definitive need for these athletes to adopt a more gradual approach to making weight, 
where BM is manipulated across longer timescales (i.e. weeks to months), therefore reducing the 
requirement to engage in methods of extreme dehydration. 
 
Combat sport athletes often complete a training camp prior to competition, ranging in duration 
from 4 to 12 weeks. Such timescales allow for the opportunity to reduce BM through an 
accumulated energy deficit, though it has been reported that these athletes may resort to dietary 
practices limiting energy intake (EI) to only one meal per day (6). These types of feeding 
strategies are likely to result in low energy availability (EA), thereby manifesting as 
consequences associated with the Male Athlete Triad or Relative Energy Deficiency in Sports 
(RED-S) models (7, 8). In the Triad model, low EA is associated with a conservation of energy 
metabolism (e.g. via hypothalamic pituitary thyroid axis disturbance, reductions in insulin-like 
growth factor-1, leptin), suppression of reproductive function (e.g. via hypothalamic pituitary 
gonadal axis disturbance, poor semen quality) and impaired bone health (9). In the RED-S 





model, these consequences are purported to further extend to impairments of metabolic rate, 
immunity, protein synthesis and cardiovascular function, all of which can be causative of 
reduced health and performance outcomes (10). Laboratory studies on females have 
demonstrated that some of these systems are perturbed at a daily EA <30 kcal·kgFFM·day
-1
, yet 
it is not yet clear whether the same threshold applies for males (11, 12). Furthermore, whilst 
experimental modulation of daily low EA often involves a consistent absolute value, it is 
possible that fluctuations in daily low EA status (i.e. via manipulation of EI and/or exercise 
energy expenditure) may reduce the risk of developing consequences associated with the Male 
Athlete Triad and RED-S (6, 13). This approach may be particularly beneficial in male athletes 
given that impairments in the hypothalamic pituitary gonadal axis can be restored within days of 
increased energy availability (14). 
 
On this basis, the aim of the present case report was to evaluate the effects of incorporating daily 
fluctuations in low EA on health and performance indices associated with the Male Athlete Triad 
and RED-S models. To this end, we monitored a male combat sport athlete for an eight week 
period whilst making weight for competition and for a one week recovery period post 
competition.  Importantly, we performed regular assessments of body composition, resting 
metabolic rate, cardiac function, maximal dynamic strength & power, cardiorespiratory capacity, 
psychological state and blood clinical chemistry to assess for biomarkers related to endocrine, 










Athlete Overview and Case Report Design 
The athlete (age: 19 years; stature: 1.66 metres; BM: 72.5 kg; Body Mass Index (BMI): 26.3 
kg·m
-2
) was a male international standard (>5 years’ experience) Taekwondo competitor, who 
typically competed 10 times per year in the <68 kg feather weight category, habitually losing 4-5 
kg across periods of 3-4 weeks prior to competition. For the present case report, the athlete 
elected to further reduce his BM, to compete in the <63 kg bantam weight category at the 2018 
British University Championships, therefore requiring a BM loss of >9.5 kg (>13%) over a 
period of 8 weeks. The implementation of an intervention to achieve this aim, as well as the 
assessment of health and performance consequences associated with the Male Athlete Triad and 
RED-S (15), were completed via a multi methodological approach, as described in the 
subsequent sections and highlighted in the supplemental content (see Figure, Supplemental 
Digital Content 1, Diagram of measurements taken throughout phases 1 & 2 intervention and 
phase 3 post competitive recovery periods, http://links.lww.com/MSS/C148). Measurements 
were taken daily and also at set intervals inclusive of 8 weeks, 4 weeks and 1 week prior to 
competition (-8 WK, -4 WK and -1 WK) as well as the day before the official competition weigh 
in (-1 D), the official competition weigh in day (WI), 24 hours post competition (+1 D) and 1 
week post competition (+1 WK). The athlete gave written informed consent and this case report 
was approved by the Liverpool John Moores University research ethics committee.  
 
Anthropometric Assessment 
Daily body mass (BM) was measured post void of the bladder/bowels between 9.00 – 9.30 hours 
after a 12 hour fast and determined to the nearest 0.01 kg on a calibrated digital scale, with 





measures of stature established to the nearest 0.1 cm using a free standing stadiometer (Seca 702 
& 123; Seca GmbH, Hamburg, Germany). Body composition was assessed via Dual X-ray 
Absorptiometry (DXA- QDR Series Discovery A; Hologic Inc., Bedford, MA, USA - software 
version 12:4:3) to generate fat free mass (FFM), fat mass (FM), percentage body fat (BF%), total 
body (minus head) and lumbar spine bone mineral content (BMC) and density (BMD) Z-scores, 
alongside anthropometric sum of 8 skinfolds (∑8SKf – Harpenden, Baty Int., West Sussex, Great 
Britain). Measurements were collected according to the DXA Best Practice Protocol (16), BMD 
and BMC as previously described (17) and ∑8SKf  adhering to the guidelines of the International 
Society for the Advancement of Kinanthropometry. Laboratory technical error of measurement 
(TEM) and coefficient of variation (CV) for DXA derived measures of FFM, FM and BF% are 
0.44 kg:1.0%, 0.37 kg:1.9%, 0.41:1.9%, respectively and for BMD measures CV is <1.5%. 
 
Resting Metabolic Rate (RMR) and RMRratio 
Measured RMR (RMRmeas) was assessed utilising indirect calorimetry (GEM Open Circuit 
Indirect Calorimeter; GEMNutrition Ltd., Warrington, UK), calibrated via known concentrations 
of O2/CO2, a zero span gas and an ethanol burn, to confirm an established respiratory exchange 
ratio (RER) of 0.67. Laboratory based TEM and CV for this system is 42 kcal·day
-1
 and <2%, 
respectively. Application of measurement and subsequent analyses were conducted according to 
the recommendations of Bone and colleagues (18) and predicted RMR (RMRpred) was calculated 
via the Cunningham equation (19). RMRratio was established by the division of RMRmeas and 
RMRpred, where a values of <0.90 were classified to define instances of potential energy 
deficiency (20). RMRmeas values below those of RMRpred were also used to calculate instances of 
adaptive thermogenesis (21). 





Blood Clinical Chemistry and Hydration Status 
All blood samples were drawn from the antecubital vein of the left arm, which were collected 
and stored as previously described (22). Measures of endocrine, bone turnover, electrolyte, renal, 
liver and lipid based biomarkers were conducted via immunoassay with chemiluminescence 
detection on Roche Cobas e601/602 and c701/702 modular analysers, utilising Rate A, 1 and 2 
point end assays and potentiometry ion selective electrode on a Roche Cobas ISE analyser 
(Roche Diagnostics Ltd. Burgess Hill, Great Britain). Plasma (Posm) osmolality was examined to 
establish hydration status via freezing point depression (Advanced Micro-Osmometer 3320, 
Advanced Instruments, Norwood Massachusetts, USA) as previously described (23). Laboratory 
individual inter/intra assay CV and sensitivity (replicates of the zero standard) for all biomarkers 
are described in the supplemental content (see Table, Supplemental Digital Content 2, CV%, 
range and sensitivity of measurement for all assessed blood clinical chemistry biomarkers, 
http://links.lww.com/MSS/C149). Measures for bone formation and reabsorption were divided to 
calculate a ratio, with values above or below one being indicative of positive or negative bone 
turnover responses, respectively. 
 
Cardiac Screening 
Cardiac scanning and subsequent analyses were conducted by a registered clinical cardiac 
physiologist prior to exercise testing via 12-lead electrocardiogram (ECG) and echocardiography 
(24). Indices of heart rate (HR), cardiac output (CO) and deformation of the left and right 
ventricles were established through alterations in the structure of the left ventricular end-diastolic 
volume (LVEDV) and right ventricular diastolic area (RVDArea), in parallel to function from left 





ventricular ejection fraction (LVEF) and right ventricular fractional area change (RVFAC). Intra 
measurement CV for all assessments was <15%. 
 
Cardiorespiratory Capacity and Substrate Utilisation Assessment  
Combined peak oxygen uptake (  O2peak) and fat oxidation rate (FATpeak) were measured via an 
online indirect calorimetry system (CPX Ultima Series; Medgraphics, Saint Paul, MN, USA) 
during an incremental exercise test performed on a motorized treadmill (h/p/cosmos Pulsar; 
h/p/cosmos Sports & Medical gmbh, Nussdorf-Trainstein, Germany) The test began with 3 
minute stages at speeds of 6 to 11 km∙hr
-1
, followed by 2 minute stages at 12, 14 and 16 km∙hr
-1
. 
The treadmill was then inclined by 1 degree each minute, until volitional exhaustion despite 
strong verbal encouragement. Raw   O2,   CO2 (L.min
-1
) and RER data were then averaged and 
converted into kilocalories (kcal) (13) and FATpeak was calculated as the highest fat oxidation 
rate, utilising the following equation: g∙min
-1
 = (1.695 x   O2) – (1.701 x   CO2) (25). Laboratory 





All tests took place in the same order as presented, under standard laboratory conditions (room 
temperature 20.0 ± 1.5°C; humidity 38.5 ± 4.0%; barometric pressure 750.2 ± 6.5mmHg) and 
were performed after a 12 hour fast between 9.00-11.00 hours. 
 
Maximal Dynamic Strength and Power Assessment 
Maximal Dynamic Strength (MDS) was assessed via one repetition maximum (1 RM) upper and 
lower bench press and back squat exercises. The athlete performed a readiness set of 10 
repetitions with a 20 kg barbell, then 10 repetitions at 50%, 5 repetitions at 75% and 1-2 
repetitions at 90% of predicted 1 RM. All subsequent 1 RM attempts were interspersed with 3 





minutes recovery and the load was exponentially increased until failure occurred. Maximal 
Dynamic Power (MDP) was examined via the same exercises for both upper and lower force 
velocity profile as previously described (26) by performing 3 maximal attempts at 20, 40, 60, and 
80% of measured 1 RM load. Concentric average power (W), force (N) and velocity (m·s
-1
) were 
recorded by a linear encoder (MuscleLab version 4010, Ergotest, Porsgrunn, Norway – software 
version 8.31) mounted perpendicular to the line of exercise movement. MDS tests were 
performed on the same day as the anthropometric and physiological assessments between 17.00-
18.00 hours, whereas MDP tests were performed at the same time on the following day. Both 
assessments were administered under standard gymnasium conditions (room temperature 21.0 ± 
1.5°C; humidity 40.5 ± 5.0%; barometric pressure 755.5 ± 3.5mmHg) after a minimum period of 
3 hours postprandial feeding. 
 
Psychological Profile 
Psychological profile was assessed by both a Profile of Moods States (POMS) (27) and semi 
structured interviews. The POMS vigour subscale was subtracted from the other combined 
subscales to generate a total mood disturbance (TMD) score. Semi structured interviews and 
subsequent questions were generated, conducted and analysed in the same manner as previous 
investigations in combat sport athletes (28) in order to reflect the athlete’s perceptions, thoughts, 
attitudes, emotions and behaviours throughout each time phase.   
 
Overview of Nutritional and Training Intervention 
Phase 1 -8 WK to -1 WK: All meals were provided for the athlete in pre-prepared packages 
with known energy and macronutrient contents equivalent to RMRmeas (1700 kcal·day
-1
 – see 





Table 1) and consisting of  3.4 g·kgFFM
-1







) and 0.9 g·kgFFM
-1
 fat (446 kcal·day
-1
). Subsequent feedings followed a 
typical daily distribution of four meals periodised in line with daily training sessions (see Table 
2). The athlete’s weekly training schedule consisted of three aerobic continuous running (CR), 
two high-intensity interval training (HIT), two resistance training (RT), three technical/tactical 
and one sparring based sessions totalling 12-15 hours·wk
-1
. Aerobic CR was conducted after a 12 
hour fasting period, for 45-60 minutes at a running speed equating to FATpeak. HIT was 
completed on a motorized treadmill in two differing activity:recovery ratios consisting of 10 x 
1:1 minutes at 120%   O2peak and 6 x 3:1 minutes at 90% of   O2peak, where the recovery period in 
both protocols was 1 minute of walking. RT was structured into whole body bi/unilateral general 
strength/speed exercises, concurrently performed in superset, with speed/strength, ballistic and 
reactive strength modalities, where volume loads and intensities were established from MDS 1 
RM testing.  
 
Phase 2 -1 WK to WI: Daily EI was reduced exponentially until WI (see Table 1), which 
consisted of low fibre, residue and sodium based foods. At -5 and -4 D, macronutrient intake 
equated to 0.5 g·kgFFM
-1











) and at -3 and -2 D, 0.3 g·kgFFM
-1





 protein (400 kcal·day
-1
) and 0.8 g·kgFFM
-1
 fat (396 kcal·day
-1
), respectively. Finally, 
at -1 D the athlete ate only one meal containing 1.4 g·kgFFM
-1
 protein (300 kcal·day
-1
). All meal 
timings corresponded to a periodised taper of training volume, consisting of aerobic CR and 
sport specific technical/tactical non-contact sessions only. From 12.00 hours on -1 D until the 
official competition weigh in at 13.00 hours, the athlete refrained from ingesting any food or 





fluids. During this time period the athlete also engaged in self-directed active and passive 
dehydration techniques, inclusive of a 1 hour sauna session at 18.00 hours and a CR at 20.00 
hours on -1 D, then a final 1 hour sauna session at 09.00 hours on WI. 
 
Phase 3 WI to + 1 WK: In the post competitive period, the athlete consumed food and fluids ad 
libitum and reported these via the remote food photography method (29). This data was assessed 
utilising dietary analysis software (Nutritics V5. Nutritics Ltd., Swords, Co. Dublin, Ireland) as 
previously described (30), to establish respective energy and macronutrient values and with 
systematic bias of measurements via independent t-tests highlighting no significant differences 
(p <0.05). This resulted in varying daily EI intakes (see Table 1) with macronutrient contents 
equating to averages of 7.9 g·kgFFM
-1
 CHO, 2.8 g·kgFFM
-1
 protein and 3.1 g·kgFFM
-1
 fat, 
respectively. Other than the competition day, exercise was completely ceased during this time 
phase. No dietary supplements were implemented or allowed throughout any time phase, to limit 
potential ergogenic effects on subsequent performance based testing. Fluid consumption 
throughout all time phases equated to an average of 2 L·day
-1 
and on -1 D was reduced to 500 ml 
until 12.00 hours. 
 
Assessment of Daily Wellbeing, Training Load, Energy Availability, Within Day Energy 
Balance and Weekly Accumulated Energy Deficit 
The athlete was requested to report perception of wellness via a Daily Well Being Score 
(DWBS) (31). Training load was assessed internally via the session rating of perceived exertion 
(s-RPE) method (32) and externally via HR chest strap (Polar V800; Polar Electro UK Ltd., 
Warwick, Great Britain), with specific profiles and zones created for each type of training 





modality, based on percentages of   O2peak. The HR wristwatch tri-axial accelerometer unit also 
acted as an activity monitor and was worn continuously for estimations of non exercise activity 
thermogenesis (NEAT). Estimated exercise energy expenditure (EEE) was assessed via an 
Actiheart combined HR and accelerometry actigraphy unit (CamNtech Ltd. Papworth, Great 
Britain) as previously described (33). Within day energy balance (WDEB) was calculated to 
examine the total daily fluctuations in 24 hour energy balance, utilising the methodology of 
Torstveit and colleagues (20), which includes additional estimations of diet induced 
thermogenesis (DIT) and excess post oxygen consumption (EPOC), respectively (see Table 2). 
Each daily WDEB measurement was added to the subsequent day, to calculate an estimated 
weekly accumulated energy deficit (WAED) across all intervention and recovery periods (see 
Figure 1 A.). Daily EA was also calculated as described by Loucks (34), where measures of EI 
were subtracted from EEE values (EEE Actiheart – NEAT + RMRmeas/60 x training in minutes) 
and divided by FFM established by DXA (see Table 1).  
 
Statistical Analysis 
In Table 1, descriptive statistics are presented as mean ± SD, where appropriate. Time phase 
combined averages for EI, DIT, NEAT, EEE, EPOC, 24 hour energy balance (24-hr EB) and EA 
were assessed via a within participant one way ANOVA utilising SPSS 26 (PASW, Chicago, 
USA). Bonferroni post hoc analysis was employed for pairwise comparisons and statistical 










Overview of Intervention and Recovery periods on Athlete Wellbeing, Training Load, Energy 
Availability, Within Day Energy Balance and Weekly Accumulated Energy Deficit 
Throughout phases 1 and 2 of the intervention period, the athlete completed all assigned sport 
specific, aerobic CR, HIT and RT sessions to meet the assigned training load and DWBS did not 
fall below a minimum threshold. Time phase assessments of energy intake, expenditure, balance 
and availability are presented in Table 1, highlighting main effects between phases when 
comparing measurements of EI (p = 0.04), DIT (p = 0.02), EEE (p = 0.02), EPOC (p = 0.02), 24-
hr EB and EA (p < 0.001). Low EA status was established throughout phase 1, with values 
ranging 7-31 kcal·kgFFM·day
-1
 equating to an average of 20 kcal·kgFFM·day
-1
.  During phase 
2, low EA status was further evident with values ranging from -4 to 9 kcal·kgFFM·day
-1
 and 
considerably lower than all other time periods (p = 0.03), due to reductions in EI (p = 0.03) 
which in turn was causative of reductions in DIT (p = 0.03). In phase 3, EA was increased 
substantially in comparison to all other time phases (p <0.001) with daily values ranging between 
53-98 kcal·kgFFM·day
-1
, accompanied by significant increases in measures of EI, DIT, and 24-
hr EB and decreases in EEE and EPOC (p <0.001). Figure 1 A highlights estimated WAED, 
demonstrating a net energy deficit of -105,757 kcal throughout phases 1 and 2, with weekly EI 
ranging from 11,900 to 3,856 kcal·wk
-1 
in parallel to mean total energy expenditures of 25,100 
kcal·wk
-1
, resulting in average deficits of -13,200 kcal·wk
-1
. In phase 3, estimated WAED is only 
rescued to a -95,984 kcal deficit, despite a considerable increase in EI totalling 36,477 kcal·wk
-1
 
and following a cessation of all training activity.  
 
 





Changes in Anthropometric Measurements 
Time phase changes of BM, Σ8SKf, FM, FFM and BF% are shown in in Figure 1 B-F. The athlete 
recorded an official weight of 62.7 kg, successfully achieving the limit for the elected weight 
category. This represented an overall BM reduction of 9.8 kg (<13.5%), consisting of a loss of 
4.9 kg (<6.8%) FM and 3.6 kg (<5.0%) FFM across phase 1 and 2 intervention periods. In the 
phase 3 post competitive recovery period, the athlete increased BM by 8.3 kg (>13.2%), FM by 
1.0 kg (>1.6%) and FFM by 7.0 kg (>11.2%). Σ8SKf were reduced by 28.5 mm across phases 1 
and 2 with a 10.4 mm increase throughout phase 3. Finally, at the cessation of phase 2 BMI was 
reduced to 22.8 kg·m
-2
, with an increase to 25.8 kg·m
-2
 at the end of the phase 3 post competitive 
recovery period. 
 
Assessment of low Energy Availability on Markers of Male Athlete Triad and RED-S 
Assessment of the athlete’s RMR is presented in Figure 2. During phases 1 and 2, there was a 
gradual reduction in RMRmeas values by -36 kcal·day
-1
 at -4 WK, -72 kcal·day
-1
 at -1 WK and a -
149 kcal·day
-1
 at -1 D, representing an overall reduction from baseline of -257 kcal·day
-1
. This 
recovers within the phase 3 post competitive recovery period by an increase of 648 kcal·day
-1
 at 
+1 WK.  Adaptive thermogenesis occurred at a rate of -36 kcal·day
-1
 at -4 WK, -99 kcal·day
-1
 at 
-1 WK and a larger decrease of -213 kcal·day
-1
 at -1 D.  In relation to RMRratio, most values 
remained within an acceptable range, with a gradual decrease across phases 1 and 2, followed by 
a substantial increase at +1 WK in phase 3. However, there was a marked reduction in RMRratio 
at -1 D of phase 2, indicating RMR suppression and potential energy deficiency. 
 





Blood clinical chemistry biomarkers and BMD/BMC measurements are presented in Table 3.  
Hypothalamic pituitary gonadal axis hormones remained relatively stable throughout phase 1, 





; follicle stimulating hormone <1.5 U∙L
-1
; sex hormone binding globulin >78 
nmol∙L
-1
) in phase 2 at WI. However, these were all rescued within 48 hours by -1 D of the phase 
3 post competitive recovery period. Fasting insulin was consistent within phases 1 and 2, but 
substantially increased above clinical reference ranges (>48 pmol∙L
-1
) throughout phase 3. Bone 
turnover markers procollagen type 1 N-terminal propeptide (P1NP) and β-carboxy-terminal 
cross-linked telopeptide (β-Ctx) were both above the highest clinical reference ranges across all 
phases (P1NP >80 ug·L
-1
; β-Ctx >0.6 ug·L
-1
), yet generating positive ratios (>1.0) at all time 
points. Additionally, DXA assessment of total body (minus head) and lumbar spine BMD were 
also within acceptable reference Z-scores, with no change across time phases as expected based 
on the time course of measurements. Predominantly all biomarkers of hydration, electrolyte, 
renal, liver and blood lipids remained stable throughout the phase 1, despite elevations in 
albumin above clinical reference ranges (>50 g∙L
-1
) across all measurement points. Within phase 
2, Posm examined in parallel with sodium, urea, creatinine and LDL was indicative of moderate 
hypohydration (>300 mOsmols·kgH2O
-1
) and hypernatremia (sodium >145 mmol∙L
-1
; urea >7.8 
mmol∙L
-1
; creatinine >110 µmol∙L
-1
; LDL >3.0 mmol∙L
-1
) at WI, however, this was rescued to 
normative values by phase 3 at +1 D. Finally, total cholesterol values were elevated above 
clinical reference ranges (>5.0 mmol∙L
-1
) in phases 2 and 3 at WI and +1 WK. 
 
Cardiac Assessment measured via ECG/echocardiography are presented in Figure 3. Despite an 
increased LVEDV response exhibited at -1 D, there were no major changes in either structure or 





function of the left (Figure 3 A) or right (Figure 3 B) ventricles across all phases. As highlighted 
in Figure 3 C, both CO and HR reduced consistently across phases 1 and 2 with a large increase 
in both measures within 24 hours from -1 D to WI, which plateaued by the end of the phase 3 
post competitive recovery period at +1 WK.  
 
There were no major psychological fluctuations in POMS or TMD scores across the majority of 
all time phases as highlighted in Table 4. This is with the exception of WI, where reductions in 
vigour and increases in fatigue resulted in an elevated TMD, yet this remained well within 
normative values for athletic populations. In all semi structured interviews and despite relevant 
probing, the athlete made no comments in regards to any gastrointestinal distresses and reported 
no incidences of illness or injury. Excerpts ascertained from these interviews highlight 
throughout phase 1, the athlete displayed feelings of ‘fear’ and ‘perceived’ losing such a large 
volume of BM would negatively affect his health and performance. In phase 2, there were 
continued emotions of ‘anxiety’ over his potential to make the required weight category, yet a 
‘realisation’ and ‘confidence’ that he will achieve his goal. Finally, post WI the athlete describes 
his ‘exhilaration’ and sense of ‘accomplishment’ in meeting the targeted weight category, 
reinforced by a renewed sense of ‘focus’ on competitive performance. 
 
Physical performance assessments of both absolute and relative upper and lower MDS, MDP and 
cardiorespiratory capacity are highlighted in Figure 4. As demonstrated in Figure 4 A, across 
time phases both upper and lower MDS increased relatively by 18-19% and absolutely by 6-9% 
(n.b. bench press was not completed during phase 3 at +1 WK, due to the athlete fracturing his 
left hand in competition). Within phase 1 from -8 WK to -1 WK, MDP improved in both upper 





absolute and lower relative force/velocity and power curve profiles (see Figure 4 B-C). Figure 4 
D highlights that across phases, both relative and absolute   O2peak values increased by 19% and 
13% at -1 WK prior to competition, respectively. There was also an improvement in the athlete’s 
FATpeak oxidation profile throughout the phase 1 intervention period from 0.62 g∙min
-1
 at 44% to 
0.72 g∙min
-1
 at 60%   O2peak. However, this is significantly reduced to 0.42 g∙min
-1
 at 30% 
  O2peak within the end of the post competitive recovery phase 3 at + 1 WK. 
 
DISCUSSION 
The aim of this case report was to evaluate the effects of incorporating daily fluctuations in low 
EA on health and performance indices associated with Male Athlete Triad and RED-S. In 
studying a male combat sport athlete making weight for competition, we provide novel data by 




permits a reduction of BM and FM without perturbations to physiological systems associated 
with Male Athlete Triad and RED-S. In contrast, a subsequent period of 5 consecutive days of 
EA <10 kcal·kg·FFM·day
-1 
induced Male Athlete Triad and RED-S consequences, as evidenced 
by disruptions to hormones of the hypothalamic pituitary gonadal axis, RMRmeas and RMRratio. 
Whilst such negative outcomes were quickly reversed during the rebound hyperphagic response 
that occurred in the 1-7 days post competition, this period of excessive EI also induced fasting 
hyperinsulinemia and hyperlipidaemia, thus suggesting impaired substrate handling and insulin 
resistance.  
 
During the 7 weeks of phase 1, the athlete adhered to a daily EI that was equivalent to RMR and 
consumed a macronutrient intake representative of high protein (2.3 g·kgFFM
-1
), low CHO (3.4 







) and low fat (0.9 g·kgFFM
-1
). However, given that absolute EEE fluctuated day by 
day during each weekly microcycle, this gave rise to a daily EA ranging from 7 to 31 
kcal·kg·FFM·day
-1
 and a mean EA of 20 kcal·kg·FFM·day
-1
. Despite the classification of low 
EA status during this phase, it is noteworthy that the athlete presented with none of the classical 
consequences associated with the Male Athlete Triad or RED-S. Indeed, we observed no 
reductions in RMR, impairments to cardiac function or clinically relevant changes in blood 
clinical chemistry. In agreement with previous case/cohort study accounts (5, 13) and 
randomised control trials (35), our data also suggest that the combination of resistance training 
and daily protein intake equivalent to 2-3 × recommended daily allowance is sufficient to 
maintain (or increase) FFM. Such findings are likely underpinned by the observation that the 
combination of increased protein intake and resistance training can maintain high rates of muscle 
protein synthesis despite low EA (36). Additionally, changes in bone turnover markers were 
consistent with normative ranges occurring in young athletic males performing high-intensity 
exercise (37), findings that also appear consistent with the observation that 5 days of EA 
equalling 15 kcal·kg·FFM·day
-1
 did not affect bone resorption or formation in healthy young 
males (38). Additionally, it is noteworthy that the athlete also presented with normal BMD 
values where in conjunction with markers of bone turnover, such data agree with previous 
observations from male amateur boxers and suggest that the physical loading associated with 
combat sport training may provide a sufficient osteogenic stimulus (39).  
 





a value commonly cited for females (40, 41), may not be representative of a 
threshold to induce health and performance consequences associated with both the Male Athlete 





Triad and RED-S models, a view recently supported by De Souza and colleagues (9, 7). Whilst 
we obviously cannot ascertain such a threshold within the present case report, it is also tempting 
to speculate that it is the daily fluctuations in EA as opposed to a consistent absolute daily EA 
(subsequently giving rise to a mean daily EA of 20 kcal·kg·FFM·day
-1
), which may have 
preserved physiological function during this phase. Indeed, such a hypothesis is supported by the 
observation that impairments in the hypothalamic pituitary gonadal axis can be restored within 
days of increased EA (14). 
 
During phase 2, the athlete underwent a tapering of EEE and consumed a reduced EI (1200-300 
kcal.d
-1
) such that absolute EA was consistently <10 kcal·kg·FFM·day
-1 
for five consecutive 
days. It is noteworthy that during this short time, the athlete subsequently presented with 
classical consequences associated with low EA that are considered indicative of Male Athlete 
Triad and RED-S, as evidenced by clinically relevant reductions to hormones of the 
hypothalamic pituitary gonadal axis, reduced RMRmeas (-258 kcal·day
-1
) and RMRratio (<0.90) 
(8). The combination of limited EI and likely associated changes to muscle glycogen 
concentration and acute dehydration, also presented as a reduction in FFM of approximately 3 kg 
when assessed via DXA. The acute dehydration period in the final 13 hours prior to the official 
competition weigh in also increased plasma osmolality, sodium, urea, creatinine and LDL. 
Whilst this magnitude of hypohydration and hypernatremia would not serve to cause acute 
kidney injury (5), these biomarkers are still markedly high considering the limited acute BM loss 
via dehydration (<3%). Additionally, in accordance with previous accounts of athletes engaging 
in low EA and acute dehydration, the final 24 hours before weigh in was associated with 
decreased vigour and increased tension and fatigue (42, 43). Nonetheless, although this increased 





both resting cardiac output and heart rate, overall cardiac structure and function remain largely 
unchanged throughout all time phases, further indicating a minimal effect of acute short term low 
EA on cardiovascular function. 
 
Despite daily low EA and the estimated WAED incurred across the intervention period (i.e. 
>105,000 kcal), it should be noted that the athlete was able to complete all prescribed training 
sessions and there were no reported incidences of illness or injury. Additionally, the athlete 
improved his MDS, MDP,   O2peak and rates of lipid oxidation, whilst also not reporting any 
impairments to mood profile. The qualitative responses of the athlete during all time phases 
consistently highlighted how the intervention was deemed a major improvement on previous 
practice, whilst also reporting feeling more prepared than he had ever been in his competitive 
career. This was further supported by the athlete achieving the gold medal at the championships, 
after successfully winning 4 contests and qualifying for his elected weight category to represent 
the national team at the 2018 European University Games.  
 
Despite the perceived success of the intervention, it is noteworthy that in the 7-day post 
competitive period (phase 3) the athlete still remained in an estimated WAED of >95,000 kcal 
when compared with baseline, despite consuming an ad libitum EI  >36,000 kcal·wk
-1
 resulting 
in a BM gain of 8.3 kg. This level of EI is indicative of rebound hyperphagia (44) and whilst not 
resulting in FM overshoot (45), there were clear signs of impaired substrate handling. Indeed, 
this period of excessive EI induced fasting hyperinsulinemia and hyperlipidaemia, thus 
suggestive of insulin resistance (46). Additionally, the athlete’s peak rate of fat oxidation during 
exercise decreased from 0.72 to 0.42 g.min
-1 
and occurred at a lower relative training intensity 





(60 to 30%   O2peak). Such periods of rebound hyperphagia are of particular concern, given that 
“weight cycling” athletes typically gain more BM upon retirement when compared with non-
weight cycling athletes (47, 48). 
 
Whilst this examination highlights novel data in relation to the effects of low EA on the health 
and performance related consequences within the Male athlete Triad and RED-S models, it 
should be noted that this is only indicative of a single participant case report and cannot be 
immediately extrapolated to wider populations. Additionally, further studies examining this 
demographic need to focus on the effects of repeated exposure to these levels of EA, considering 
combat sport athletes consistently make weight numerous times per year across long spanning 
careers.  
 
In summary, we provide novel data by demonstrating in a male combat sport athlete that 7 weeks 





reduction of BM and FM without perturbations to physiological systems associated with the 
Male Athlete Triad and RED-S. Importantly, the athlete was able to complete all prescribed 
training sessions during this time and improved his physical performance capacity without any 
impairment to mood profiles.  In contrast, a subsequent period of five consecutive days of EA 
consistently <10 kcal·kg·FFM·day
-1 
and acute dehydration induced markers of Male Athlete 
Triad and RED-S, as evidenced by reductions in hormones of the hypothalamic pituitary gonadal 
axis and lowered RMR. Again these data are only indicative of a single participant case report 
and caution should be considered when extrapolating these conclusions to wider populations 
without the support of ongoing longitudinal and cohort based investigations. Additionally, 





further studies are now required using randomised control trials to ascertain the threshold and 
time course of EA that induces impairments in physiological function of male athletes. Finally, 
we encourage all athletes who engage in BM reduction to do so with the guidance of qualified 
sport dieticians/nutritionists, to reduce the potential for health and performance consequences of 
low EA across both acute and chronic timeframes. 
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FIGURE 1. Changes in estimated weekly accumulated energy deficit and energy intake (A.), 
body mass (B.), fat mass (C.), fat free mass (D.), body fat % (E.) and Σ8SKf (F.) measurements 
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FIGURE 2. Changes in resting metabolic rate measurement, prediction and ratio assessments 
throughout the intervention and post competitive recovery phases. 
FIGURE 3. Changes in left (A.) and right (B.) ventricular structure/function and cardiac 
output/heart rate (C.) throughout the intervention and post competitive recovery phases. 
FIGURE 4. Changes in absolute and relative upper/lower maximal dynamic strength (A.), upper 
(B.) and lower (C.) maximal dynamic power and cardiorespiratory capacity (D.) throughout the 
intervention and post competitive recovery phases. 
TABLE 1.  Measurements of energy intake, expenditure and 24 hour within day energy 
balance/availability throughout the intervention and post competitive recovery phases. 
TABLE 2. Within day energy balance calculations for a training day 5 during the Phase 1 -8 WK 
time period of the intervention. 
TABLE 3. Changes in blood clinical chemistry and DXA bone mineral density and content 
measurement throughout the intervention and post competitive recovery phases. 
TABLE 4. Changes in profile of mood states and total mood disturbance scores throughout the 
intervention and post competitive recovery phases. 
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TABLE 1.  Measurements of energy intake, expenditure and 24 hour within day energy 






MONDAY TUESDAY WEDNESDAY THURSDAY FRIDAY SATURDAY SUNDAY 
TIME PHASE 
COMBINED AVE. 
PHASE 1 -8 WK to -4 WK         
EI (kcal·day-1) 1700 ± 0 1700 ± 0 1700 ± 0 1700 ± 0 1700 ± 0 1700 ± 0 1700 ± 0 1700 ± 0 
DIT (kcal·day-1) 167 ± 0 170 ± 0 171 ± 0 170 ± 0 169 ± 0 171 ± 0 170 ± 0 170 ± 2 
NEAT (kcal·day-1) 1794 ± 90 1270 ± 64 1235 ± 62 986 ± 49 682 ± 34 911 ± 46 1073 ± 54 1136 ± 352 
EEE (kcal·day-1) 873 ± 47 584 ± 31 409 ± 22 617 ± 34 1209 ± 66 0 ± 0 376 ± 20 559 ± 370 
EPOC (kcal·day-1) 70 ± 4 47 ± 2 33 ± 2 49 ± 3 97 ± 5 0 ± 0 30 ± 1 45 ± 30 
24-hr WDEB (kcal·day-1) -2843 ± 94 -2034 ± 66 -1824 ± 63 -1782 ± 54 -2069 ± 53 -1091 ± 46 -1077 ± 55 -1919 ± 541 
EA (kcal·kgFFM·day-1) 15 ± 1 20 ± 1 24 ± 0 20 ± 1 9 ± 1 31 ± 0 24 ± 0 20 ± 7 
PHASE 1 -4 WK to -1 WK          
EI (kcal·day-1) 1700 ± 0 1700 ± 0 1700 ± 0 1700 ± 0 1700 ± 0 1700 ± 0 1700 ± 0 1700 ± 0 
DIT (kcal·day-1) 167 ± 0 170 ± 0 171 ± 0 170 ± 0 169 ± 0 171 ± 0 170 ± 0 170 ± 2 
NEAT (kcal·day-1) 1503 ± 75 1176 ± 59 1173 ± 59 1436 ± 72 686 ± 34 1523 ± 76 944 ± 47 1207 ± 313 
EEE (kcal·day-1) 968 ± 52 527 ± 29 340 ± 18 616 ± 34 1333 ± 72 0 ± 0 430 ± 23 579 ± 418 
EPOC (kcal·day-1) 77 ± 4 43 ± 2 27 ± 1 49 ± 3 107 ± 6 0 ± 0 35 ± 2 46 ± 34 
24-hr WDEB (kcal·day-1) -2611 ± 82 -1846 ± 61 -1657 ± 60 -2194 ± 75 -2162 ± 57 -1667 ± 76 -1516 ± 49 -1974 ± 401 
EA (kcal·kgFFM·day-1) 13 ± 1 22 ± 1 25 ± 0 20 ± 1 7 ± 1 31 ± 0 23 ± 0 20 ± 8 
PHASE 2 -1 WK to COMP       OCWI COMP † 
EI (kcal·day-1) 915 915 863 863 300 3490 5185 794 ± 538* 
DIT (kcal·day-1) 92 92 421 86 30 330 464 79 ± 39* 
NEAT (kcal·day-1) 632 1097 903 1122 929 937 507 855 ± 289 
EEE (kcal·day-1) 1120 409 421 467 474 0 337 423 ± 407 
EPOC (kcal·day-1) 98 33 34 37 38 0 27 34 ± 33 
24-hr WDEB (kcal·day-1) -2729 -2280 -2108 -2340 -2622 809 2394 -2165 ± 476 
EA (kcal·kgFFM·day-1) -4 9 8 7 -3 64 89 3 ± 7* 
PHASE 3 +1 D to +1 WK         ⸸ 
EI (kcal·day-1) 3877 3203 4637 2978 3717 3902 5490 5211 ± 2672# 
DIT (kcal·day-1) 395 352 432 332 325 451 885 567 ± 398# 
NEAT (kcal·day-1) 1042 851 390 723 599 494 136 767 ± 260 
EEE (kcal·day-1) 0 0 0 0 0 0 0 48 ± 127# 
EPOC (kcal·day-1) 0 0 0 0 0 0 0 4 ± 10# 
24-hr WDEB (kcal·day-1) 879 332 2038 39 801 855 2369 1387 ± 1180# 
EA (kcal·kgFFM·day-1) 69 57 83 53 66 70 98 73 ± 17# 





Daily data for combined time phases are presented as mean ± SD with singular values representing 
individual daily time points within specified time phases. *significantly different to all other equitable 
measurements at phases 1 and 3 (p < 0.05). #significantly different to all other equitable measurements at 
phases 1 and 2 (p < 0.05). 
OCWI
Official competition weigh in day.
 COMP
Competition day. †Calculated with 
values prior to OCWI. ⸸Calculated with values post OCWI. (WK = Week; D = Day; EI = Energy Intake; 
DIT = Diet Induced Thermogenesis; NEAT = Non Exercise Activity Thermogenesis; EEE = Exercise 
Energy Expenditure; EPOC = Excess Post Oxygen Consumption; 24-hr WDEB = 24 hour Within Day 
Energy Balance; EA = Energy Availability) 





TABLE 2. Within day energy balance calculations for a training day 5 during the Phase 1 -8 WK 
time period of the intervention. 
 INTAKE EXPENDITURE HOURLY CALCULATIONS 
TIME EI DIT EEE EPOC NEAT SMR RMR TEE hr to hr EB hr by hr WDEB 
00.00-01.00 0 2 0 0 0 71 0 74 -74 -8465 
01.00-02.00 0 0 0 0 0 71 0 145 -71 -8536 
02.00-03.00 0 0 0 0 0 71 0 216 -71 -8607 
03.00-04.00 0 0 0 0 0 71 0 287 -71 -8679 
04.00-05.00 0 0 0 0 0 71 0 359 -71 -8750 
05.00-06.00 0 0 0 0 0 71 0 430 -71 -8821 
06.00-07.00 0 0 0 0 0 71 0 501 -71 -8892 
07.00-08.00 0 0 0 0 46 0 71 618 -117 -9009 
08.00-09.00 0 0 0 0 46 0 71 735 -117 -9126 
09.00-10.00 0 0 0 0 46 0 71 852 -117 -9243 
10.00-11.00 0 0 246* 0 46 0 71 1215 -363 -9606 
11.00-12.00 379 11 0 12 46 0 71 1355 238 -9368 
12.00-13.00 0 11 0 7 46 0 71 1490 -135 -9502 
13.00-14.00 0 7 187^ 0 46 0 71 1801 -311 -9813 
14.00-15.00 595 22 0 9 46 0 71 1098 446 -9367 
15.00-16.00 0 19 0 6 46 0 71 2091 -142 -9509 
16.00-17.00 0 13 0 0 46 0 71 2221 -130 -9638 
17.00-18.00 595 25 0 0 46 0 71 873 453 -9185 
18.00-19.00 0 21 0 0 46 0 71 2501 -138 -9323 
19.00-20.00 0 14 364# 0 46 0 71 2995 -495 -9818 
20.00-21.00 0 7 364# 18 46 0 71 3502 -506 -10324 
21.00-22.00 131 8 0 29 46 0 71 3656 -23 -10347 
22.00-23.00 0 6 0 11 0 71 0 3744 -88 -10435 
23.00-00.00 0 2 0 0 0 71 0 3818 -74 -10509 
24 hr TOTAL 1700 169 1162 93 684 641 1069 3818 -2118 -10509 





*Fasted Aerobic Continuous Running ^Resistance Training #Sport Specific Training (EI = Energy Intake; 
DIT = Diet Induced Thermogenesis; NEAT = Non Exercise Activity Thermogenesis; EEE = Exercise 
Energy Expenditure; EPOC = Excess Post Oxygen Consumption; SMR = Sleeping Metabolic Rate; RMR 
= Resting Metabolic Rate; TEE hr to hr = Total Energy Expenditure Hour to Hour; EB hr by hr = Energy 
Balance hour by hour; WDEB = Within Day Energy Balance) n.b. Measures have been rounded to whole 
numbers owing to 24 hr totals which may not equate 





TABLE 3. Changes in blood clinical chemistry and DXA bone mineral density and content 
measurement throughout the intervention and post competitive recovery phases. 
↓represents decrease and ↑ represents increase outside of normative clinical reference ranges (IGF-1 = 
Insulin-like Growth Factor 1; SHBG = Sex Hormone Binding Globulin; P1NP = Procollagen type 1 N-
terminal propeptide; β-CTX = β-carboxy-terminal cross-linked telopeptide; BMD = Bone Mineral 
Density; BMC = Bone Mineral Content (values in parentheses);  Posm = Plasma Osmolality; HDL = High 
Density Lipoprotein; LDL = Low Density Lipoprotein; WK = Week; D = Day; WI = Official competition 
weigh in 
 PHASE 1 PHASE 2 PHASE 3 
 -8 WK -4 WK -1 WK -1 D WI +1 D +1 WK 
ENDOCRINE RESPONSES        
Cortisol (nmol·L-1) 501 465 498 482 571 407 407 
Testosterone (nmol·L-1) 21.5 18.7 11.2 9.4 4.0 ↓ 9.7 19.8 
IGF-1 (nmol·L-1) 32 30 25 22 21 21 30 
Luteinizing Hormone (U·L-1) 3.4 3.2 2.1 1.8 1.0 ↓ 3.1 4.0 
Follicle Stimulating Hormone (U·L-1) 1.9 1.9 1.9 1.7 1.4 ↓ 2.0 2.1 
SHBG (nmol·L-1) 43 57 57 72 82 ↑ 72 46 
Insulin (pmol·L-1) 26 34 28 26 21 142 ↑ 77 ↑ 
BONE TURNOVER & DXA BMD/BMC        
P1NP (ug·L-1) 112 ↑ 159 ↑ 131 ↑ 124 ↑ 112 ↑ 132 ↑ 139 ↑ 
β-Ctx (ug·L-1) 0.7 ↑ 0.9 ↑ 1.0 ↑ 0.9 ↑ 0.9 ↑ 0.6 ↑ 1.0 ↑ 
Total Body (minus head) BMD/BMC (Z-score/g·cm2) 0.4 (1.123) 0.5 (1.135) 0.4 (1.130) 0.7 (1.155) - - 0.4 (1.122) 
Lumbar Spine BMD/BMC (Z-score/g·cm2) 0.8 (1.144) 0.8 (1.154) 1.0 (1.175) 1.0 (1.169) - - 0.9 (1.166) 
ELECTROLYTE, RENAL & LIVER FUNCTION        
Posm (mOsmols·kgH2O
-1) 288 294 294 299 307 ↑ 297 289 
Sodium (mmol·L-1) 144 143 143 142 147 ↑ 143 142 
Urea (mmol·L-1) 4.2 5.8 5.6 6.6 8.3 ↑ 4.8 4.2 
Creatinine (µmol·L-1) 93 94 99 109 119 ↑ 92 93 
Albumin (g·L-1) 56 ↑ 57 ↑ 52 ↑ 55 ↑ 59 ↑ 53 ↑ 52 ↑ 
Globulin (g·L-1) 25 23 22 22 25 21 22 
Total Protein (g·L-1) 78 80 74 77 84 ↑ 72 71 
LIPID PROFILES        
Total Cholesterol (mmol·L-1) 3.6 3.8 4.3 4.6 5.2 ↑ 3.9 5.1 ↑ 
HDL (mmol·L-1) 1.3 1.2 1.3 1.4 1.6 1.3 1.7 
LDL (mmol·L-1) 2.1 2.3 2.7 2.9 3.3 ↑ 2.0 2.9 
Triglyceride (mmol·L-1) 0.5 0.7 0.6 0.6 0.6 1.5 1.5 





TABLE 4. Changes in profile of mood states and total mood disturbance scores throughout the 
intervention and post competitive recovery phases. 
 PHASE 1 PHASE 2 PHASE 3 
 -8 WK -4 WK -1 WK -1 D WI +1 D +1 WK 
Tension (AU) 5 7 9 5 8 13 1 
Depression (AU) 3 6 8 4 4 2 0 
Anger (AU) 3 6 9 10 9 7 1 
Vigour (AU) 22 24 21 22 11 19 24 
Fatigue (AU) 3 6 1 3 12 0 7 
Confusion (AU) 6 6 6 5 6 3 1 
Total Mood Disturbance Score (AU) -2 7 12 5 28 6 -14 
WK = Week; D = Day; WI = Official competition weigh in 
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